3 results about "Aripiprazole" patented technology

The present application relates to aripiprazole synthesis technical field, specifically to a kind of preparation of 1-(2,3-dichlorophenyl) piperazine hydrochloride substantially without following dimer impurity compound (I), the structure of the impurity is determined to clarify the generation mechanism of the impurity, provide the train of thought for better control of the impurity and make corresponding judgment to the impurity derived subsequently, provide help to the quality research of subsequent intermediates and finished products;The present application replaces the existing multiple recrystallization process by means of filtration and salting-out, which can effectively simplify the operation and greatly reduce the use of organic solvents.

Described is a composition comprising (a) a population of particles of an aripiprazole prodrug having a volume based particle size (Dv50) of less than 1000 nm and (b) at least one surface stabilizer comprising an adsorbed component which is adsorbed on the surface of the aripiprazole prodrug particles and a free component available for solubilisation of the aripiprazole prodrug. The surface stabilizer to prodrug ratio provides the optimal quantity of free surface stabilizer for the purposes of producing a lead-in formulation. Also described are methods of treatment using the aforementioned composition.

This invention relates to blends comprising carbamate compounds for the prevention, relief, or treatment of schizophrenia, the blends comprising a carbamate compound of Formula 1, or a pharmaceutically acceptable salt, solvate, or hydrate thereof, and more specifically, to blends and pharmaceutical compositions comprising a carbamate compound of Formula 1 and aripiprazole, respectively, and their use in the treatment of schizophrenia.